Taylor & Francis announce iOpenAccess

["Acreman, Beverley" <Beverley.Acreman@tandf.co.uk>]

Taylor & Francis announce iOpenAccess - giving authors the choice

Taylor & Francis are today delighted to announce the introduction 
of an "iOpenAccess" option for authors publishing in 175 journals 
from T&F's Chemistry, Mathematics and Physics portfolios, one 
behavioural science journal from Psychology Press, and medical 
and bioscience journals from Informa Healthcare.

>From October 2006, all authors whose manuscripts are accepted for 
publication in one of the iOpenAccess journals will have the 
option to make their articles freely available to all via the 
Journal's website for a one-off fee of $3100.

Commenting on the launch of the initiative, Journals Publishing 
Director, Dr David Green, stated: "Taylor & Francis has a strong 
tradition of meeting the needs of the academic and scientific 
research communities over more than two centuries. We are 
introducing "iOpenAccess" only after the widest possible 
consultation with the editor, author and funder communities.  We 
are doing so in a manner which will continue to guarantee the 
integrity of peer review and the rights of authors, and which 
will ensure the continuing viability and quality of major 
international journals with whose publishing stewardship we are 
entrusted."

Mark Walport, Director of the Wellcome Trust, commented: "I am 
very pleased that Taylor and Francis are now offering an open 
access choice to publish in their journals. We all want to 
maximise the impact of biomedical research. Ensuring the widest 
distribution of the results of biomedical research is a key part 
of achieving that aim."

* Authors will be asked to grant a publishing licence or assign 
copyright in the normal way. Selection of the "iOpenAccess" 
option and payment of the appropriate fee will then allow the 
article to be made available to all under a Creative Commons 
Licence (Attribution-Non-commercial-No Derivatives version 2.5 ). 
Under this licence we will allow tagging and cross-referencing of 
articles within repositories so that they relate back to the 
original research grants and programmes.

* Authors selecting the "iOpenAccess" option will have no embargo 
restriction on posting their version of the published article to 
any institutional or subject repository.  Where appropriate, we 
will facilitate deposit on behalf of authors into PubMedCentral.

* We undertake to review the subscription prices of each journal 
with respect to the uptake of the iOpenAccess initiative, and the 
relevant information will be published on each journal's home 
page at www.tandf.co.uk/journals

Our commitment to stringent, independent, expert peer review 
remains: only accepted articles are eligible for the scheme, and 
authors will only be offered the open access option when they are 
sent their proofs for review.  This complete separation of 
payment from the peer review and acceptance process will ensure 
that editorial independence and quality are not compromised.

This initiative is a pilot 'hybrid' open access scheme in 
selected subjects, and comes after the experience of a number of 
years' experimentation with access schemes operated by various 
T&F journals, as well as wide consultation with our editors, 
society partners and research funders. We intend to increase the 
number of iOpenAccess journals over the coming months, and fees 
may vary as we expand this initiative into other subject areas

Taylor & Francis has a justified reputation as a leading 
publisher and trusted partner of learned societies for over 200 
years.  Through a combination of organic growth and acquisitions 
it has become one of the world's leading imprints for academic 
books and journals.  The name Taylor & Francis has long been 
associated with a pre-eminent tradition of scholarly science 
publishing.

Taylor & Francis Group
www.tandf.co.uk/journals

####